BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...
Ajinomoto Bio-Pharma Services is taking full control of an API manufacturing facility in India as the CDMO continues to bulk up in a market that favors companies that can do it all. Ajinomoto ...
LONGMONT, Colo.--(BUSINESS WIRE)--Avista Pharma Solutions, Inc. (“Avista Pharma”) has completed facility upgrades that effectively double the company’s API manufacturing capacity at its Longmont, ...
KD Pharma, a Swiss API maker of omega-3 products, has snapped up a manufacturing site in Seal Sands, U.K., for an undisclosed price. The company said the acquisition will allow it to expand capacity ...
India, May 2 -- A pharma-chemical stock is drawing attention as a long-stagnant manufacturing business looks to enter a stronger growth phase through new API expansion plans. The company has built ...
Rising API prices from China and feedstock disruptions amid the West Asia crisis are tightening cost pressures on India's ...
LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today reported strong growth in 2022 in both its long-established Active Pharmaceutical Ingredient ...
EMPOWER'S KAI Medical Laboratory Also Supporting API Pharma With Health Canada Submission of COVID Rapid Antigen Test and Signs National Distribution Agreement VANCOUVER, BC / ACCESSWIRE / November 30 ...
For companies such as HRV Pharma out of India, the standardized scale of manufacturing has expanded alongside its ...
POTOMAC, MD / ACCESS Newswire / May 12, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company") today announced that it presented its latest scientific poster, titled "Genetic Toxicity ...
Medylife Global FZE Leader Mr Salim Khan Medylife Global FZE is one of the fastest growing pharmaceutical company engaged in the business of Pharma API At Medylife Global FZE, we work every day to ...
Union Budget 2026 | Investor attention is expected to turn to active pharmaceutical ingredient (API) makers, specialty drug companies, and organised diagnostics after the Union Budget 2026-27, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results